Buccal mucosa in vitro experiments I. Confocal imaging of vital staining and MTT assays for the determination of tissue viability

被引:28
作者
Imbert, D [1 ]
Cullander, C [1 ]
机构
[1] Univ Calif San Francisco, Sch Pharm, Dept Biopharmaceut Sci, San Francisco, CA 94143 USA
关键词
buccal mucosa; viability; confocal microscopy; MTT assay; vital staining;
D O I
10.1016/S0168-3659(98)00143-6
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Delivery of drugs through the skin and the buccal mucosa has been considered as an alternative to per oral dosing for those substances that are degraded in the gastro-intestinal tract, or are subject to first-pass metabolism in the liver. In the buccal mucosa, contrary to skin, the diffusion barriers are located within living cell layers, hence the physiological state of the tissue is likely to significantly affect in vitro diffusion profiles. In this study, we were interested in assessing the viability of excised buccal mucosa and determining the limits of tissue usage under common in vitro experimental conditions. Using confocal laser scanning microscopy (CLSM), we have shown that optical sectioning of samples exposed to calcein AM and ethidium homodimer-1 (used as 'live' and 'dead' cell probes respectively) can be employed to accurately and reliably determine the viability of buccal mucosa biopsies. The results of the CLSM assay were remarkably consistent with that of an MTT assay. In both studies, viability in PBS at 34 degrees C was lost after about 8 h post-mortem, whereas it could be sustained for up to 24 h in KBR. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:39 / 50
页数:12
相关论文
共 43 条
[11]   QUANTITATIVE REDUCTION OF MTT BY HEARTS BIOPSIES IN-VITRO IS AN INDEX OF VIABILITY [J].
FERRERA, R ;
LARESE, A ;
BERTHOD, F ;
GUIDOLLET, J ;
RODRIGUEZ, C ;
DUREAU, G ;
DITTMAR, A .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1993, 25 (09) :1091-1099
[12]   HIGH EXPRESSION LEVELS OF THE ERYTHROID BRAIN TYPE GLUCOSE TRANSPORTER (GLUT1) IN THE BASAL CELLS OF HUMAN EYE CONJUNCTIVA AND ORAL-MUCOSA RECONSTITUTED IN CULTURE [J].
GHERZI, R ;
MELIOLI, G ;
DELUCA, M ;
DAGOSTINO, A ;
GUASTELLA, M ;
TRAVERSO, CE ;
DANNA, F ;
FRANZI, AT ;
CANCEDDA, R .
EXPERIMENTAL CELL RESEARCH, 1991, 195 (01) :230-236
[13]   COMPARISON OF [H-3] THYMIDINE INCORPORATION WITH MTT-AND MTS-BASED BIOASSAYS FOR HUMAN AND MURINE IL-2 AND IL4 ANALYSIS - TETRAZOLIUM ASSAYS PROVIDE MARKEDLY ENHANCED SENSITIVITY [J].
GIENI, RS ;
LI, Y ;
HAYGLASS, T .
JOURNAL OF IMMUNOLOGICAL METHODS, 1995, 187 (01) :85-93
[14]   DRUG DELIVERY VIA THE MUCOUS-MEMBRANES OF THE ORAL CAVITY [J].
HARRIS, D ;
ROBINSON, JR .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1992, 81 (01) :1-10
[15]   THE QUANTITATIVE REDUCTION OF 2,3,5-TRIPHENYL TETRAZOLIUM CHLORIDE BY SKIN INVITRO [J].
HERSHEY, FB ;
CRUICKSHANK, CND ;
MULLINS, LI .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1958, 6 (03) :191-196
[16]  
HOOD HL, 1996, FUNDAM APPL TOXICOL, V30, P168
[17]  
HOOGSTRAATE AJ, 1993, ADV DRUG DELIVER REV, V12, P99
[18]   Effects of bile salts on transport rates and routes of FITC-labelled compounds across porcine buccal epithelium in vitro [J].
Hoogstraate, AJ ;
Senel, S ;
Cullander, C ;
Verhoef, J ;
Junginger, HE ;
Bodde, HE .
JOURNAL OF CONTROLLED RELEASE, 1996, 40 (03) :211-221
[19]   In vivo buccal delivery of the peptide drug buserelin with glycodeoxycholate as an absorption enhancer in pigs [J].
Hoogstraate, AJ ;
Verhoef, JC ;
Pijpers, A ;
vanLeengoed, LAMG ;
Verheijden, JHM ;
Junginger, HE ;
Bodde, HE .
PHARMACEUTICAL RESEARCH, 1996, 13 (08) :1233-1237
[20]  
Imbert D, 1998, J DENT RES, V77, P290